Success rate of Orlistat in primary-care practice is limited by failure to follow prescribing recommendations: the referral letter content vs clinical reality
- 23 October 2003
- journal article
- other
- Published by Springer Science and Business Media LLC in International Journal of Obesity
- Vol. 27 (11), 1434-1435
- https://doi.org/10.1038/sj.ijo.0802401
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Long‐Term Medication Use and Weight Loss Maintenance: An Observational StudyObesity Research, 2001
- Effect of sibutramine on weight maintenance after weight loss: a randomised trialThe Lancet, 2000
- Referral letters to an obesity unit—relationship between doctor and patient informationInternational Journal of Obesity, 2000
- The effect of orlistat on body weight and coronary heart disease risk profile in obese patients: The Swedish Multimorbidity StudyJournal of Internal Medicine, 2000
- Weight Loss, Weight Maintenance, and Improved Cardiovascular Risk Factors after 2 Years Treatment with Orlistat for ObesityObesity Research, 2000
- Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y studyThe American Journal of Clinical Nutrition, 1999
- Long-term maintenance of weight loss after a very-low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramineAmerican Journal Of Medicine, 1999
- Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patientsThe Lancet, 1998